COVID-19 Ambulatory Therapies:
A Deeper Dive

After this series, participants will be able to describe the drug class, mechanism of action, and clinical indications/usage for COVID therapeutics for ambulatory patients following current NIH guidelines.

COVID-19 Ambulatory Therapies: A Deeper Dive

Audience:
Physicians, nurse practitioners or other advanced practice nurses, physician assistants and infection preventionists working in Colorado

Commitment:
Three weekly ECHO sessions held virtually
Thursdays 7:00 - 8:00 AM MT
February 17 - March 3

SIGN UP FOR THIS SERIES

CME:
Our application is pending approval. Participants should claim only the credit commensurate with the extent of their participation in the series (1.0 credit per session; up to 3 credits in total).

  • ECHO SESSION 1

    Paxlovid and Sotrovimab

    February 17, 2022

  • ECHO SESSION 2

    Remdesivir and Molnupiravir

    February 24, 2022

  • ECHO SESSION 3

    Other Ambulatory Therapeutic Considerations (Bebtelovimab, Dexamethasone, Evusheld, and others)

    March 3, 2022

SIGN UP FOR THIS SERIES Contact ECHO Colorado